Fig. 1From: Celastrol-based nanomedicine promotes corneal allograft survivalCorneal graft rejection. A The clear cornea before rejection and the opaque cornea and a large number of corneal neovascularization after rejection. B A mass of inflammatory cells infiltrated into the rejected corneal graft. C Most of the infiltrating inflammatory cells expressed CD68 and iNOS positive in the rejected cornea. Bar = 20 μmBack to article page